Michael Wright

Michael Wright has extensive work experience in product management and leadership roles in various companies. Michael is currently working as the Senior Director of Product Management at MIM Software Inc. Prior to that, they held the position of AVP, Product Management at Hyland, where they led the strategic direction of the Hyland industry portfolio and oversaw three Business Delivery Units. Michael also served as the Sr Director, Product Management - Healthcare (Clinical Content & Enterprise Imaging) at Hyland, where they created a long-term strategic vision for the healthcare vertical and introduced best practices in product management.

Before joining Hyland, Michael served as a Member of the Board of Directors at both Prevent Biometrics and NAVIS MEDICAL CORPORATION. Michael also worked as a Commercialization Director (Med Device) at Cleveland Clinic, where they played a key role in enabling spin-off companies based on Cleveland Clinic technology.

In addition, Michael has experience in the medical device industry, having worked as a Senior Product Manager at Integra LifeSciences, with responsibility for 16 products, and as a Global Product Manager at STERIS Corporation, where they directed the worldwide launch of a sterilizer product.

Earlier in their career, Michael worked as a Product Manager in the rehabilitation division at Invacare and as a Software Applications Engineer at RoviSys.

Overall, Michael Wright has a diverse background in product management, strategic leadership, and board-level positions, with a strong focus on healthcare and medical device industries.

Michael Wright's education history includes an MBA degree in Marketing & Entrepreneurship from the Weatherhead School of Management at Case Western Reserve University. Michael also holds a bachelor's degree (BS) in Electrical/Computer Engineering from Villanova University. In addition to their formal education, Michael has obtained an Advanced B2B Portfolio Management Certification from Product Management University in July 2021.